Masimo Corporation   Report issue

For profit Phase 1
Founded: Irvine CA United States (1989)
Status: No NME R&D (1989)

Organization Overview

First Clinical Trial
2012
NCT01342328
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Masimo Labs

Active Ingredients

Drugs in Phase 1 Trials (2)

hydromorphone (diladid) (1 trial)

morphine (1 trial)

Drugs in Other Trials (3)

dexmedetomidine (precedex) (1 trial)

propofol (diprivan) (1 trial)

sodium chloride (1 trial)

Indications

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 5